• People
  • Locations
  • Careers

Matthew is a Chartered Patent Attorney and European Patent Attorney and heads up our Cambridge Biotechnology and Life Sciences Group.

Matthew specialises in the preparation and prosecution of patent applications in the biotechnology, pharmaceuticals, biologics and healthcare fields. He regularly provides due diligence and freedom-to-operate advice to his clients in various technical areas and has particular expertise in diagnostic technologies; specifically biomarkers, applications of next generation sequencing and personalised medicine, especially companion diagnostics, therapeutics including antibodies, vaccines and CAR-T, analyte detection technologies including bacterial detection, gene editing, fermentation processes, stem cell technologies and medical devices. He brings strategic and commercial advice to his clients and has extensive experience of supporting early stage companies seeking investment and development partners. He has also worked on a Patent Attorney’s Report for an Initial Public Offering of a pharmaceutical company specialising in plant derived medicines.

Matthew is highly experienced in developing drafting and prosecution strategies for key client portfolios worldwide. He regularly represents his clients in Oral Proceedings before the Opposition and Appeal Boards of the European Patent Office.

Matthew speaks and publishes on various aspects of biotechnology and healthcare patenting. He has an MA Cantab (Natural Sciences) from Cambridge University which focused on biochemistry, molecular cell biology, chemistry and plant sciences and enables Matthew to practice in a wide range of biochemical and chemical technology areas. He also has an MSci Biochemistry also from Cambridge University in which Matthew engineered protein isoforms of a splicing regulator protein. He has a postgraduate certificate in Intellectual Property Law from Queen Mary & Westfield College, University of London and was awarded the Chartered Institute of Patent Agents Drafting prize for his performance in the finals examination.





One Nucleus


Registered UPC Representative

Chartered UK Patent Attorney (awarded the Chartered Institute of Patent Attorneys Drafting prize)

European Patent Attorney

MA (Cantab) Natural Sciences, University of Cambridge

MSci Biochemistry, University of Cambridge





Medical devices


Practice areas



Cancer immunotherapies

Companion diagnostics

Enzymatic detection


Gene therapy


Molecular biology

Nucleic acid based technologies

Plant derived pharmaceuticals

Proteins and peptides therapeutics

RNAi in plants

Small molecule imaging agents

CPC4 Capital Park
Cambridge Rd
CB21 5XE
Download my vCard


Recommended Individual by IAM Patent 1000, 2023

Named as a key attorney by Legal 500, 2023

Listed as a World Leading Patent Professional, 2022, by IAM Patent 1000

Recommended individual, IAM Patent 1000, 2021

Recommended in IAM Patent 1000, 2020

Boult Wade Tennant was ranked Tier One by Legal 500 for both Patent and Trade Mark groups in 2020 and Matthew was recognised as a key attorney.

Recommended in IAM Patent 1000, 2019

Recommended in IAM Patent 1000, 2018

View all insights

Contact us

    The information you submit will exclusively be used to answer your enquiry. Find out exactly how we store and use your personal data in our privacy policy.

    A European award-winning patent and trade mark firm delivering world-class advice to enhance the commercial value of intellectual property rights globally.